Fieldnote / Guide

Bring better questions to the first visit

A short preparation plan for an online or in-person tirzepatide consultation.

You do not need to arrive at a consultation knowing which product or dose to request. The useful preparation is a clear account of your health, the medicines you take, and what you want help with.

A good visit should leave you with reasons you understand, including the possibility that tirzepatide is not the right next step. This fieldnote helps make room for that discussion.

Bring your history and your questions. Leave with a product name, a follow-up plan, and an explanation of the decision.

Make a one-page starting record

List current prescriptions, over-the-counter medicines, supplements, and allergies. Add relevant diagnoses and previous weight-management or diabetes treatments, including what helped and what was difficult. Bring recent records if the practice requests them; do not order tests solely because an advertisement mentions them.

Describe practical goals in your own words. Those might involve managing an established condition, feeling more able to move, or understanding treatment options. The clinician should connect those goals to a medical assessment rather than simply agree to a product selection.

Sources: FDA: Managing medicine benefits and risks · NIDDK: Prescription medicines for overweight and obesity

Ask what is being treated and with which product

Ask the clinician to name the proposed product and explain its intended purpose. Zepbound, Mounjaro, and compounded tirzepatide are not three spellings of the same approved treatment. Our brand comparison is a useful preparation read.

If the proposal is compounded, ask why an approved drug would not meet your needs and which pharmacy would fill it. If the answer is uncertain, make that an unresolved question. You do not need to settle it by paying for a shipment.

Sources: Lilly: Zepbound prescribing information · Lilly: Mounjaro prescribing information · FDA: Concerns with unapproved GLP-1 drugs

Discuss safety before logistics

Bring up personal and family thyroid-cancer history, pregnancy considerations, significant digestive problems, and any planned procedures. This is not the full assessment: your clinician must decide what else matters. Mention other diabetes medicines because some combinations can increase the risk of low blood sugar.

Ask which symptoms warrant an ordinary call, a same-day assessment, or emergency care. The side-effect fieldnote gives context, but your own product instructions and clinician’s plan should guide you.

Sources: Lilly: Zepbound prescribing information · Lilly: Mounjaro prescribing information

Finish with the practical handoff

Before the visit ends, confirm how to contact the prescriber, when follow-up occurs, and how refills are reviewed. Ask who teaches use of the prescribed presentation and who answers pharmacy questions. For telehealth, confirm that the clinician can treat you where you will physically be during the appointment.

Use our cost guide to request a complete estimate. You can copy a short question list from the visit notebook. If an answer is rushed or unclear, write it down as something to resolve before starting.

Sources: HHS: Licensing across state lines · FDA: Managing medicine benefits and risks · FDA: Buying medicines from online pharmacies

The source shelf

  1. FDA: Managing medicine benefits and risks

    General questions for clinical decision-making and medication follow-up.

  2. NIDDK: Prescription medicines for overweight and obesity

    Chronic weight-management decisions and ongoing lifestyle care.

  3. Lilly: Zepbound prescribing information

    Current approved-product label, revised August 2026; does not establish equivalence of compounded preparations.

  4. Lilly: Mounjaro prescribing information

    Product-specific diabetes indications and safety information. Not an interchangeable label for compounded tirzepatide.

  5. FDA: Concerns with unapproved GLP-1 drugs

    Compounding, fraudulent labels, dosing errors and the limits of adverse-event reports. Checked September 23, 2026.

  6. HHS: Licensing across state lines

    The patient location affects telehealth licensure requirements; a place page does not verify a provider.

  7. FDA: Buying medicines from online pharmacies

    Checks for prescription requirements, licensing, contact details and pharmacy support.

A good next read